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ABSTRACT
Gene expression array technology has reached the
stage of being routinely used to study clinical
samples in search of diagnostic and prognostic
biomarkers. Due to the nature of array experiments,
which examine the expression of tens of thousands
of genes simultaneously, the number of null
hypotheses is large. Hence, multiple testing correc-
tion is often necessary to control the number of
false positives. However, multiple testing correction
can lead to low statistical power in detecting genes
that are truly differentially expressed. Filtering out
non-informative genes allows for reduction in the
number of null hypotheses. While several filtering
methods have been suggested, the appropriate
way to perform filtering is still debatable. We
propose a new filtering strategy for Affymetrix
GeneChips, based on principal component
analysis of probe-level gene expression data.
Using a wholly defined spike-in data set and one
from a diabetes study, we show that filtering by
the proportion of variation accounted for by the
first principal component (PVAC) provides increased
sensitivity in detecting truly differentially expressed
genes while controlling false discoveries. We
demonstrate that PVAC exhibits equal or better
performance than several widely used filtering
methods. Furthermore, a data-driven approach
that guides the selection of the filtering threshold
value is also proposed.
INTRODUCTION
Microarrays are routinely used to simultaneously examine
the expression of thousands or tens of thousands of genes
in various tissues and species (1). In recent years, there has
been an increase in the use of array technology to
study clinical samples in search of biomarkers and gene
expression signatures for improved diagnosis and progno-
sis (2–5). Hence, the quality and the reproducibility of
the data become critically important (6,7).
One of the main applications of microarrays is to
identify differentially expressed genes (DEGs) between
two or more groups of biological samples. DEGs are
identiﬁed through statistical testing on a gene by gene
level. Given the nature of the array experiments where
tens of thousands of genes (or probe sets) are printed on
an array, the number of null hypotheses to be tested is
large. Hence, multiple testing correction is often necessary
in order to control for the number of false positives.
One of the commonly used methods for multiple testing
control is the false discovery rate (FDR) (8), which is the
expected ratio of the number of false rejections among the
total number of rejections. While FDR adjustment on raw
P-values is effective in controlling false positives, it is
associated with reduced power to detect truly DEGs.
In a typical experiment, the percentage of true positives
among all the genes present on an array is often times
low (usually <10%). Detecting such a small percentage
of DEGs with enough statistical power is clearly
challenging.
One strategy to tackle the issue of low power is to
reduce the number of null hypotheses by ﬁrst ﬁltering
out non-informative genes and then perform hypothesis
testing only on the genes that pass the ﬁlter (i.e. the
so-called two-stage approach) (9,10). Filtering is
motivated by the fact that most whole-genome arrays
are designed to be used to detect changes in expression
levels in all tissue types and treatment conditions.
However, it is well-known that, under a given condition,
many genes on an array are not expressed, expressed at
low levels, or expressed at levels with no biological signiﬁ-
cance. In fact, it has been estimated that in a given tissue
only 30–40% of the genes are expressed at array detectable
levels (11). From a recent study using deep sequencing
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0.3 reads per kilobase exon model per million mapped
reads (RPKM), the number of genes expressed in human
and mouse tissues is estimated to be 60–70% of RefSeq
coding genes (12). Given that the sensitivity of array plat-
forms is generally considered lower than deep sequencing
(with enough sequence depth), clearly a signiﬁcant per-
centage of genes are either not expressed or beyond the
detection limit in a typical array experiment. Filtering out
this group of genes would potentially be beneﬁcial to DEG
detection. Furthermore, it has been shown that probe set
ﬁltering increases concordance between Affymetrix and
quantitative reverse transcription–PCR (qRT–PCR)
expression measurements (13).
There are a number of ﬁltering methods available in the
literature (9,10,14–16). The most commonly used ﬁlter
statistics include the fraction of ‘Present’ calls for
Affymetrix arrays, the overall mean and the overall vari-
ance. Note that these statistics are calculated across all
samples (i.e. arrays) by ignoring the sample class labels.
Therefore, these approaches are also called non-speciﬁc
ﬁlters. It has been suggested that the non-speciﬁc ﬁlters
should be preferred as they do not interfere with down-
stream statistical analyses (10,17). Based on several real
and simulated data sets, Hackstadt and Hess (9)
concluded that the variance ﬁlter is superior to the mean
ﬁlter. Similarly, using a Leukemia data set Bourgon et al.
(10) showed that the mean ﬁlter generally produced fewer
rejections than the variance ﬁlter. Due to the sub-
jective nature of ﬁltering, comparing different methods
can be difﬁcult and additional comparisons using different
control data sets are warranted. Moreover, questions still
remain on how to select the threshold in ﬁltering and
whether further improvements can be made.
On the Affymetrix platform, one uses a probe set
containing multiple 25-bp oligonucleotides probes to rep-
resent a gene. For this type of array, Talloen et al. (16)
recently introduced a ﬁltering technique named inform-
ative/non-informative calls (I/NI-calls). This method was
derived from the summarization algorithm, factor analysis
for robust microarray summarization (FARMS) (18).
It entails the utilization of Bayesian factor analysis on
probe level data and ﬁltering out the genes by the
variance of a factor. One nice feature about their
method is that in their model the variance of the factor
can capture the correlation between probes. As all probes
in a probe set are designed to target the same transcript or
a transcript cluster (19), these probes should largely
perform concordantly when gene expression is measured.
In this report, we propose a new strategy to ﬁlter
non-informative features based on gene expression from
Affymetrix arrays. We explore the correlation feature
between probes by conducting principal component
analysis (PCA) on the probe-level data, and use the vari-
ability captured by the ﬁrst principal component (PC1) as
a measure of consistency among probes in a probe set.
Our strategy is in principle similar to Talloen’s method,
but differs in several ways: (i) our method does not rely on
any distribution assumptions, (ii) no selection of an in-
formative prior is required and (iii) our approach is
much simpler and thus potentially more practical for
data analysts to use. Based on a well-deﬁned spike-in
control data set (where we know the true differences in
transcript concentrations between the two groups) and
a real data set from a diabetes study, we show that ﬁltering
by the proportion of variation accounted by PC1 (PVAC)
provides increased sensitivity in detecting DEGs and is on
par with, or outperforms several competing methods.
Furthermore, a data-driven approach is developed to
guide the selection of the ﬁltering threshold value.
MATERIALS AND METHODS
Data sets
Affymetrix spike-in data set (20) is available from the
NCBI Gene Expression Omnibus (GEO) (21) (accession
number GSE21344). It includes a total of 18 samples
divided into two groups. More than 5000 RNAs are
spiked in at fold changes ranging from 1 to 4. In this
experiment the RNA amount, direction and magnitude
of fold change are balanced between the two groups.
This data set is termed ‘Platinum Spike’, reﬂecting an
improved experimental design over the previous design
of the ‘Golden Spike’ data set (22).
The diabetes data set is also available from GEO
(accession number GSE5606) (23). This data set includes
14 samples (seven diabetic rats and seven controls). Gene
expression was measured using the Affymetrix Rat
GeneChip 230 2.0 array with a total of 31099 probe
sets on the chip.
Affymetrix data preprocessing
Data analysis was performed using R (24) with
Bioconductor packages (25). Raw CEL ﬁles were pro-
cessed using the robust multichip average (RMA) algo-
rithm available in the affy package (26) with steps
including background correction, quantile normalization
and summarization by the median polish approach (27).
The log2 scale data from RMA was used in statistical
testing. The MAS5 presence/absence (P/A) calls were
acquired using the affy package. The P/A detection call
is based on the Wilcoxon signed rank tests for comparing
perfect match (PM) and the corresponding mismatch
(MM) probes in a probe set (19). Such calls are made
for each probe set in every study sample.
PCA
We performed PCA (28) on probe-level data matrices.
Given a probe set, the raw probe-level data were ﬁrst
background-corrected and quantile normalized as in the
RMA procedure. We then applied the log2 transformation
and transposed the data matrix to place the probes on the
columns and the samples on the rows. Furthermore, we
scaled the data matrix to have zero mean and unit
variance for each data column before performing the
PCA.
PCA is a commonly used technique for dimension
reduction (28,29). Consider a probe set with n probes, a
data set with m samples and the dimension of the scaled
probe-level data matrix X is m n. The singular value
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U is orthonormal (U
T U=I, the identity matrix),   is a
diagonal matrix containing the associated singular values
 , and the rows of matrix V are also orthonormal (VV
T=I).
The singular values, { 1,  2,  3,...,  k}, are often ranked
(from highest to lowest), with the largest squared value
representing the amount of variation accounted for by
the ﬁrst PC (PC1). Given the fact that all probes are
designed to detect the same target message RNA level,
the full probe level data matrix should be largely
approximated by PC1. Hence, we chose the ratio:
S ¼
 2
1 Pk
i¼1  2
i
i.e. the proportion of variance accounted for by the PC1
among the total variance, as a measure of probe consist-
ency, and used it as our ﬁlter criteria. The R code for
performing the full analysis is available from the
Bioconductor repository (version 2.8 and later) (25).
Evaluating statistical signiﬁcance and power comparison
For comparison purposes, we used the same statistic, the
t-test with equal variance as used in (9) and (10), to rank
genes in each hypothesis test. For the spike-in data set,
statistical signiﬁcance was also evaluated using the limma
t-statistic available in the package limma (30). For a given
gene g, limma ﬁts a linear model and tests the null hypoth-
esis H0: g=0, where  g is the contrast of interest. To test
this hypothesis, a moderated t-statistic ~ tg is constructed as:
~ tg ¼
d0+dg
dg
   1=2 ^  g ﬃﬃﬃﬃﬃﬃﬃﬃ
s2
 vg
p
where s2
  ¼ s2
g+ðd0+dgÞs2
0, and vg is the scaling factor of the
variance estimates of ^  g: This statistic is derived based on
a hierarchical model where unknown gene-level variances
 2
g are modeled by a scaled inverse chi-square distribution,
with d0 and s2
0 as hyperparameters.
The power of tests after various ﬁltering was compared
by receiver operating characteristic curves (ROC) (22,31).
Speciﬁcally, given the true differential expression status of
each probe set, we computed and plotted the proportion
of true positives being detected against the proportion
of false discoveries among the total rejections at various
t-statistic threshold values.
RESULTS
An overview of PCA-based ﬁltering
Two steps are involved in PCA-based ﬁltering (Figure 1).
First, for each individual probe set, PCA is performed on
a transposed probe-level data matrix (i.e. samples on rows
and probes on columns), including all the study samples.
The probe data matrices are derived from the CEL ﬁles
after the steps of RMA background correction and
quantile normalization. We performed PCA and used
the proportion of variation explained by PC1 (PVAC) to
measure the degree of consistency among probes within a
probe set. Second, we derived an empirical distribution of
the PVAC scores of the probe sets that are called ‘Absent’
by the Affymetrix MAS5.0 calling algorithm (19) across
all the study samples. We then chose the 99% percentile
value of this distribution (with a maximum value of 0.5,
i.e. 50% of the total variation) as the threshold, and
applied it to all the probe sets on the chip (i.e. ﬁltering
out probe sets with PVAC scores less than the threshold
value).
Power assessment of ﬁltering methods using a spike-in
data set
Given the subjective nature of ﬁltering, it is impractical to
compare every scenarios (e.g. at various threshold values)
with different methods. Here, we conducted a basic
comparison between PVAC and the two most commonly
used ﬁltering strategies, under a reasonable threshold:
(i) Filtering by the Present/Absent calls—we used the
same criterion as in (9), i.e. ﬁlter out a probe set if there
are no ‘Present‘calls for the probe set in any of the study
samples. (ii) Filtering by overall variance—ﬁrst the overall
variance was calculated for each probe set and then the
variances were ranked. Then, any probe set with its
variance ranked below the median (50%) value was
ﬁltered out. The same criterion was recommended by (9)
and was used in (10).
We compared these ﬁltering methods based on a
well-deﬁned spike-in experiment (20). This data set
contains a total of 18 samples (with nine in each group)
and about 18707 probe sets, among which 1944 are truly
Figure 1. A diagram of the work-ﬂow for performing PCA-based
ﬁltering. For each probe set, the PCA is performed on the background
corrected, quantile normalized probe-level data matrix, where the
probes are in columns and samples in rows. The proportion of vari-
ation accounted by PC1 was extracted and used for measuring con-
cordance of probes. A cutoff was chosen based on the distribution of
the same statistic among a subset of probe sets that are called ‘Absent’
across all samples by the MAS5 algorithm. See the ‘Materials and
Methods’ section for details.
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ranging from 1.2- to 4-fold), 3426 were spiked-in at an
equal amount between the two groups, and the remaining
13337 probe sets are considered non-expressed genes.
For comparison, we used the same t-test for differential
expression detection as in (9) and (10).
The performance of the ﬁltering methods was compared
based on ROC curves where we plotted the true positive
rate (on y-axis) against the observed FDR (on x-axis)
calculated on the known status of each probe set.
Figure 2 shows the ROC curves drawn based on all the
data (nine replicates, n=18, panel A), and on subsets of
data with six replicates (n=12, panel B) and with three
replicates (n=6, panel C). Random sampling of inde-
pendent subsets of data (i.e. n=12 and n=6) produced
similar results (data not shown). In all three data sets, each
ﬁltering method being evaluated showed increased power
compared to that without ﬁltering. For data sets with a
large number of replicates (nine or six), variance-based
ﬁltering seems to have slightly better performance at
a low FDR threshold. However, overall it is similar to
the other ﬁltering strategies. In contrast, for the data set
with three replicates, PVAC consistently outperformed
both the A/P-call based and variance based ﬁltering
approaches. The increased power from the PVAC
score-based method is not due to the shorter gene list
after ﬁltering. Filtering out the same number of genes
with the variance ﬁlter does not attain the same level
of statistical power as the PVAC approach (Figure 3).
We consider such an improvement in power for small
sample-size experiments signiﬁcant as few replicates are
commonly used in biological experiments mainly due to
cost constraints.
To further examine the effect of PVAC score-based
ﬁltering, we plotted the PVAC scores against the t-statis-
tics for all the probe sets with known expression states
(Figure 4). Overall, scores from the vast majority of
non-expressed probe sets are relatively low, and the
scores as well as the t-statistics from DEGs are relatively
high. The probe sets that were spiked-in with equal
amounts in the two groups showed low t-statistics, but
nearly uniform distribution on the PVAC scores. These
results suggest that the beneﬁts of ﬁltering seem to
largely result from ﬁltering out non-expressed genes.
Next we investigated the effect of sample size on the
distribution of PVAC scores which is directly relevant to
the selection of cutoff values for ﬁltering. Figure 5 illus-
trates the distribution of PVAC scores for the data sets
with different sample sizes. It can be seen that the overall
distribution of PVAC scores shifts to the left as the sample
size increases. Note that the small peak in the distribution
at the far right of the histogram could be due to singularity
Figure 2. Power comparisons of different ﬁltering methods by ROC curves based on the spike-in data set. Here the proportions of true DEGs
detected are drawn against the observed FDRs, derived from applying various ﬁlters and performing the two-sample t-test. Note that the compari-
sons were performed on the full data set with nine replicates in each group (left), a subset of samples with six replicates (middle) and a subset with
three replicates (right).
Figure 3. Power comparison between the variance and the PCA-based
ﬁlters given a ﬁxed number of ﬁlter-passing genes. By adjusting the
threshold value of the ranked overall gene-level variances, the same
number of genes as those passing the PVAC ﬁlter (n=3848) were
chosen for statistical testing. The power comparison through ROC
curves is based on the same subset of data (with n=3) as shown in
Figure 2, right hand side. For comparison, a random set with the same
number of probe sets were drawn and compared to those from the
variance and PVAC ﬁlters.
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leads to a higher total number of principal components in
PCA (with a maximum being the number of probes in
a probe set). This in general leads to a lower PVAC
score. Therefore, the change in the distribution of scores
with different data sets requires a data-dependent adjust-
ment of threshold values for ﬁltering.
A case study: diabetes data set
Using a rodent model of diabetic cardiomyopathy
(DCM), Glyn-Jones et al. (23) compared gene expression
in the cardiac left ventricles of seven diabetic rats with
seven controls. There are a total of 31099 probe sets on
the chip (Affymetrix, Rat GeneChip 230 2.0 array). This
data set was also analyzed by Hackstadt and Hess (9)
in order to evaluate variance-based ﬁltering using a
two-sample t-test with equal variance. Here, we applied
the same strategy but with PVAC. The distribution of
PVAC scores is shown in Figure 6. Applying the
strategy described previously, we set the PVAC score
cutoff value at 0.45 in order to ﬁlter out low-consistency
probe sets.
Using RMA preprocessed values and at a 5%
Benjamini and Hochberg adjusted FDR, Hackstadt and
Hess identiﬁed 710 DEGs using variance-based ﬁltering,
and 781 by applying A/P call based-ﬁltering. Applying
PVAC to the same preprocessed data set and with the
same criteria, we identiﬁed 20% more (855) DEGs than
applying the variance ﬁlter method. Besides the difference
in numbers, we also examined the lists of the top 700 genes
from the three methods (Figure 7). While about 70% (484)
of the genes can be found by either of the three ﬁlters,
using PVAC seemed to be able to identify more unique
genes than those from applying the other two ﬁlters
(93 versus 41 and 46). We examined the probe-level
expression of the probe sets uniquely identiﬁed by each
of the three methods (Figure 8). As expected, the probe
sets identiﬁed by PVAC tend to show more consistent
probe performance (i.e. similar consistent expression)
than those identiﬁed by either the A/P call ﬁlter or the
variance ﬁlter.
DISCUSSION
Bourgon et al. (10) pointed out that an ideal ﬁltering
criterion should be independent of test statistics under
the null hypothesis (i.e. no differential expression), but
correlated under the alternative. Our approach to gene
Figure 4. PVAC scores versus t-statistics. Here the PVAC scores and
the t-statistics were calculated on the subset of data with three
replicates in each group. Each dot in the ﬁgure represents a probe
set, colored by one of the three possible states (i.e. no expression,
expressed but no difference between the two groups, and differentially
expressed). The t-statistics were set to 10 if values >10.
Figure 6. Overall distribution of the PVAC scores from the diabetes
data set. The distribution of the observed PVAC scores is plotted (in
dark), along with the density of the PVAC scores from the probe sets
called ‘Absent’ across all samples, i.e. the non-expressed sets (in gray).
The gray vertical line indicates the 99 percentile value from the
non-expressed sets, which is chosen as the threshold for ﬁltering.
Figure 5. Inﬂuence of the sample size on the distribution of PVAC
scores. Here the overall distribution of the PVAC scores are plotted
based on the full data set (n=9) and subsets of the spike-in data set
(n=6 and n=3). rep denotes replicates.
PAGE 5 OF 8 Nucleic Acids Research,2011, Vol.39, No. 13 e86ﬁltering, based on PCA on the probe-level data, ﬁts well in
this category (Figure 4). Besides the increase in statistical
power as demonstrated by the spike-in data set, our ﬁlter-
ing method has two major advantages compared to the
variance- and A/P call-based ﬁltering approaches:
(i) unlike the ﬁltering criteria used in the other two
methods, the one used here (the PVAC score) is interpret-
able. It represents the percentage of total variation in the
probe data explained by the PC1. As all probes in a probe
set are designed to target a common mRNA transcript
(or a common cluster of transcripts), the PVAC score
also measures the degree of consistency among the
probes in a probe set. High level of probe consistency in
a probe set is desirable, whereas probe sets containing low
consistency probes would be difﬁcult to validate experi-
mentally. (ii) Although a subjective cutoff is utilized,
we have provided an intrinsic way to guide the selection
of a threshold for ﬁltering based on the distribution of
PVAC scores in a subset of probe sets selected by the
MAS5 calls. In this regard, we have taken a hybrid
approach to gene ﬁltering.
Most of our attention has been directed to comparing
our PVAC method to the A/P call- and variance-based
ﬁltering approaches using RMA summarized values.
We also compared our PVAC-based ﬁltering with the
I/NI-calls method based on the spike-in data sets. Here,
the FARMS summarized values with either a Laplacian or
a normal prior for the factor were used as inputs for
I/NI-calls, but the same RMA summarized values (of
only the informative probe sets) were used for subsequent
statistical testing and comparison with the PVAC ﬁltering
approach. For the case of the normal prior of the factor
(Supplementary Data Figure S1), I/NI-calls ﬁltering seems
to be too stringent in the case of replicates (rep)=9 and
rep=6, but perform slightly better than the PVAC with
rep=3. For the case of the Laplacian prior of the factor
(Supplementary Data Figure S2), the I/NI-calls method
shows similar performance with rep=9 and rep=6,
but performs slightly worse than PVAC with rep=3. A
limitation of the Bayesian factor analysis approach is that
the selection of an informative prior may not always be
easy. Although similar in overall performance, the PVAC
method seems to show a slight edge in selecting the ﬁlter-
ing threshold value than the I/NI-calls method. Also,
unlike the I/NI-calls, the PVAC approach does not rely
on any distribution assumptions which can be difﬁcult to
verify for real data.
Here, the comparison between different ﬁltering
methods is based on a simple two-sample t-test. We also
performed the same comparison on the spike-in data set
Figure 8. Heatmap of probe-level data for genes selected by each ﬁltering method. The probe-level data are shown for the differentially expressed
probe sets uniquely identiﬁed by the A/P ﬁlter (388665_at), the variance ﬁlter (1380348_at), and by the PVAC ﬁlter (1389772_at). For each probe set,
the probe-level data (on each row) were scaled to mean 0 and unit variance for displaying in the heatmap, with the groups labeled as 1 and 2 and the
probe identiﬁers shown on each row. The red and green colors represent high and low probe intensity, respectively.
Figure 7. Venn diagram of the lists of top ranked genes from various
ﬁlters. Here the top ranked genes (n=700) identiﬁed as differentially
expressed (FDR<0.05) in the diabetes data set are compared after
applying the A/P ﬁlter, the variance and the PVAC ﬁlters. The same
ﬁltering procedure were chosen as those used in Figure 2 (see ‘Results’
section for details).
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Bayesian approach was used to model the gene-speciﬁc
variances with an inverse  
2 distribution (30). We
observed a similar improvement in power with ﬁltering,
although the increase in power is less dramatic than that
from the regular t-test (Supplementary Data Figure S3).
As expected, even without ﬁltering, the limma t-statistic
performs signiﬁcantly better than the two-sample t-test,
implying that the limma t-statistic has overlapping but a
somewhat different role than ﬁltering in identifying the
non-expressed genes or those beyond the detection limit.
Bourgon et al. (10) argued against combining the limma
t-statistic with ﬁltering, as ﬁltering may lead to a skewed
distribution of the gene-level error variances. From the
empirical data, it is clear that both the limma moderated
t-statistic and ﬁltering show some strength in improving
power (Supplementary Data Figure S3). Further investi-
gation on how to best combine the two procedures is
warranted.
Another remaining question is how ﬁltering affects
multiple testing correction for controlling the
experiment-wide Type-I error. It has been pointed out
that applying the FDR adjustment to post-ﬁltered
P-values is closely related to weighted FDR control
(WFDR) (32), where a common weight is assigned to
genes passing the ﬁlter and weight zero for the genes
that are ﬁltered out (10). It is worth mentioning that
using the same spike-in data set, Zhu et al. (20) showed
that, even without ﬁltering, there are discrepancies
between the observed FDR and predicted FDR. This
indicates that further research on FDR control is still
needed.
One obvious limitation with ﬁltering by PVAC is that it
can only be applied to the Affymetrix array platform, as
the probe-level data is needed. Also, it may be useful to
explore robust methods for PCA, although this could be
challenging with a small sample data set. Besides being an
effective ﬁlter, it should be pointed out that a probe set
PVAC score derived from the probe-level data can also be
used as a quality measure of the probe set. This would
generally be useful in selecting genes for further experi-
mental validation, even in situations where no ﬁltering is
performed.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR online.
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